143 related articles for article (PubMed ID: 21243426)
1. Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.
Galoian K; Temple TH; Galoyan A
Neurochem Res; 2011 May; 36(5):812-8. PubMed ID: 21243426
[TBL] [Abstract][Full Text] [Related]
2. Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.
Galoian KA; Temple TH; Galoyan A
Tumour Biol; 2011 Aug; 32(4):745-51. PubMed ID: 21494810
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 inhibition and ECM-cell adhesion-independent drug resistance via PI3K-AKT and PI3K-RAS-MAPK feedback loops.
Galoian K; Temple HT; Galoyan A
Tumour Biol; 2012 Jun; 33(3):885-90. PubMed ID: 22246604
[TBL] [Abstract][Full Text] [Related]
4. Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.
Galoian K; Scully S; McNamara G; Flynn P; Galoyan A
Neurochem Res; 2009 Dec; 34(12):2117-21. PubMed ID: 19484491
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
[TBL] [Abstract][Full Text] [Related]
6. Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.
Galoian KA; Guettouche T; Issac B; Qureshi A; Temple HT
Tumour Biol; 2014 Mar; 35(3):2335-41. PubMed ID: 24178909
[TBL] [Abstract][Full Text] [Related]
7. Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.
Galoian K; Abrahamyan S; Chailyan G; Qureshi A; Patel P; Metser G; Moran A; Sahakyan I; Tumasyan N; Lee A; Davtyan T; Chailyan S; Galoyan A
Int J Oncol; 2018 Jan; 52(1):139-154. PubMed ID: 29138803
[TBL] [Abstract][Full Text] [Related]
8. Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.
Galoian K; Scully S; Galoyan A
Neurochem Res; 2009 Feb; 34(2):379-85. PubMed ID: 18612811
[TBL] [Abstract][Full Text] [Related]
9. Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.
Galoian K; Luo S; Qureshi A; Patel P; Price R; Morse AS; Chailyan G; Abrahamyan S; Temple HT
Mol Clin Oncol; 2016 Nov; 5(5):618-624. PubMed ID: 27900099
[TBL] [Abstract][Full Text] [Related]
10. Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells.
Galoian K; Qureshi A; Wideroff G; Temple HT
Mol Clin Oncol; 2015 Jan; 3(1):171-178. PubMed ID: 25469290
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-proliferative effects of mTOR and MEK inhibitors in high-grade chondrosarcoma cell line OUMS-27.
Fukumoto S; Kanbara K; Neo M
Acta Histochem; 2018 Feb; 120(2):142-150. PubMed ID: 29397960
[TBL] [Abstract][Full Text] [Related]
12. Baicalin Induces Apoptotic Death of Human Chondrosarcoma Cells through Mitochondrial Dysfunction and Downregulation of the PI3K/Akt/mTOR Pathway.
Zhu M; Ying J; Lin C; Wang Y; Huang K; Zhou Y; Teng H
Planta Med; 2019 Mar; 85(5):360-369. PubMed ID: 30469147
[TBL] [Abstract][Full Text] [Related]
13. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway.
Shui X; Zhou C; Lin W; Yu Y; Feng Y; Kong J
Exp Biol Med (Maywood); 2017 May; 242(10):1044-1050. PubMed ID: 28399646
[TBL] [Abstract][Full Text] [Related]
15. SF2523 inhibits human chondrosarcoma cell growth in vitro and in vivo.
Zhu JX; Xiao JR
Biochem Biophys Res Commun; 2019 Apr; 511(3):559-565. PubMed ID: 30824188
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.
Wu MH; Lo JF; Kuo CH; Lin JA; Lin YM; Chen LM; Tsai FJ; Tsai CH; Huang CY; Tang CH
J Cell Physiol; 2012 Aug; 227(8):3016-26. PubMed ID: 21959927
[TBL] [Abstract][Full Text] [Related]
18. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
Zhu Z; Wang CP; Zhang YF; Nie L
Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
[TBL] [Abstract][Full Text] [Related]
20. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
